Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history
Abstract Two-dose messenger RNA vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 infection. However, the durability of protection is not known, nor is the effectiveness against emerging viral variants. Additiona...
Guardado en:
Autores principales: | Thomas W. McDade, Alexis R. Demonbreun, Amelia Sancilio, Brian Mustanski, Richard T. D’Aquila, Elizabeth M. McNally |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e2609c3fe644fae88cd30f4096e7e76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples
por: Amelia E. Sancilio, et al.
Publicado: (2021) -
Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies
por: David A. Garber, et al.
Publicado: (2020) -
Plasma C-reactive protein is lower among marijuana using HIV-negative individuals but not among persons living with HIV
por: Ethan Morgan, et al.
Publicado: (2021) -
FURTHER DEVELOPMENT OF “IgY-TECHNOLOGY”: AN ELISA SYSTEM BASED ON SPECIFIC ANTIBODIES FROM EGG YOLKS AS A SURROGATE VARIANT OF THE NEUTRALIZATION TEST
por: A. P. Ivanov, et al.
Publicado: (2018) -
Toward a surrogate marker of malaria exposure: modeling longitudinal antibody measurements under outbreak conditions.
por: Joseph J Campo, et al.
Publicado: (2011)